バイオニック義肢と外骨格の世界市場レポート2025-2031

QY Research > レポート一覧 > 機械及び設備 > バイオニック義肢と外骨格の世界市場レポート2025-2031

英文タイトル： Global Bionic Prosthetics and Exoskeletons Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1214921
発表時期：2025-10-03
訪問回数：112
ページ数：162
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：157
レポートカテゴリ：機械及び設備

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、バイオニック義肢と外骨格の世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別にバイオニック義肢と外骨格市場を分類しています。

本レポートでは、世界のバイオニック義肢と外骨格市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートはバイオニック義肢と外骨格の主要生産者を調査するとともに、主要地域や国の消費状況も提供します。バイオニック義肢と外骨格の主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Ekso Bionics
Lifeward
Cyberdyne
Open Bionics
SUITX Exoskeletons
Marsi Bionics
Ottobock
Esper Bionics
Bionic
Coapt
Blatchford
FAULHABER GROUP
Parker Hannifin

タイプ別市場セグメント：
Upper Limbs
Lower Limbs
Whole Body

用途別市場セグメント：
Military
Civilian
Medical
Others

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界のバイオニック義肢と外骨格市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてバイオニック義肢と外骨格市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）のバイオニック義肢と外骨格生産量、成長率、市場シェアを調査しています。
二. 消費面では、バイオニック義肢と外骨格の売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーのバイオニック義肢と外骨格売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界のバイオニック義肢と外骨格市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本バイオニック義肢と外骨格レポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：バイオニック義肢と外骨格レポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：バイオニック義肢と外骨格の世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：バイオニック義肢と外骨格の現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：バイオニック義肢と外骨格メーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：バイオニック義肢と外骨格の下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：バイオニック義肢と外骨格のグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米におけるバイオニック義肢と外骨格市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州におけるバイオニック義肢と外骨格市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域のバイオニック義肢と外骨格市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米におけるバイオニック義肢と外骨格市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域のバイオニック義肢と外骨格市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：バイオニック義肢と外骨格の主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：バイオニック義肢と外骨格のサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：バイオニック義肢と外骨格の市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Bionic Prosthetics and Exoskeletons market is projected to grow from US$ 1803 million in 2024 to US$ 6229 million by 2031, at a CAGR of 19.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Bionic prosthetics and exoskeletons utilize advanced technology and robotics to restore vital functions and provide support for amputees, people with disabilities, and those in need. Bionic prosthetics are artificial limbs that combine sensors, motors, control systems, and feedback systems to simulate human limb movement and function. They can replace limb function, provide intelligent control, and enhance perception. Exoskeletons are external wearable devices that provide additional strength, support, and protection to the human body through external structures, enhancing mobility, reducing burdens, and supporting rehabilitation. Bionic prosthetics and exoskeletons have a wide range of applications in military, civilian, and rehabilitation medicine.

The bionic prosthetics and exoskeleton market has primarily benefited from advances in sensor technology, AI control, and myoelectric interfaces. An increasing number of products are able to simulate real limb functions and improve users' quality of life. The global market size is currently growing steadily, with an overall rapid growth trend. However, due to their highly customized nature, these products remain expensive, making it difficult to achieve economies of scale and thus price reductions. From a regional perspective, North America holds the majority of the market share, owing to its advantages of well-developed health infrastructure, high R&D investment, and supportive medical reimbursement mechanisms. The Asia-Pacific region is experiencing the fastest growth, driven primarily by an aging population, industrial labor demand, and government support. The European market is experiencing steady growth, driven by factors such as labor safety and aging trends. Furthermore, exoskeletons are expanding in both medical rehabilitation and military applications. The bionic prosthetics market is more focused on medical and civilian applications, but high prices and a high level of customization continue to limit widespread adoption.

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Bionic Prosthetics and Exoskeletons market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Ekso Bionics
Lifeward
Cyberdyne
Open Bionics
SUITX Exoskeletons
Marsi Bionics
Ottobock
Esper Bionics
Bionic
Coapt
Blatchford
FAULHABER GROUP
Parker Hannifin

Segment by Type
Upper Limbs
Lower Limbs
Whole Body

Segment by Application
Military
Civilian
Medical
Others

Production by Region
North America
Europe
China
Japan

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina

Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Bionic Prosthetics and Exoskeletons study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Bionic Prosthetics and Exoskeletons: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bionic Prosthetics and Exoskeletons Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Upper Limbs
1.2.3 Lower Limbs
1.2.4 Whole Body
1.3 Market Segmentation by Application
1.3.1 Global Bionic Prosthetics and Exoskeletons Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Military
1.3.3 Civilian
1.3.4 Medical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Bionic Prosthetics and Exoskeletons Revenue Estimates and Forecasts 2020-2031
2.2 Global Bionic Prosthetics and Exoskeletons Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bionic Prosthetics and Exoskeletons Sales Estimates and Forecasts 2020-2031
2.4 Global Bionic Prosthetics and Exoskeletons Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis
3.1 Global Bionic Prosthetics and Exoskeletons Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan

4 Competition by Manufacturers
4.1 Global Bionic Prosthetics and Exoskeletons Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Bionic Prosthetics and Exoskeletons Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Upper Limbs Market Size by Manufacturers
4.5.2 Lower Limbs Market Size by Manufacturers
4.5.3 Whole Body Market Size by Manufacturers
4.6 Global Bionic Prosthetics and Exoskeletons Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis
5.1 Global Bionic Prosthetics and Exoskeletons Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Bionic Prosthetics and Exoskeletons Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats

6 Global Downstream Application Analysis
6.1 Global Bionic Prosthetics and Exoskeletons Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Bionic Prosthetics and Exoskeletons Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application

7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Bionic Prosthetics and Exoskeletons Sales and Revenue by Type (2020-2031)
7.4 North America Bionic Prosthetics and Exoskeletons Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Bionic Prosthetics and Exoskeletons Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico

8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Bionic Prosthetics and Exoskeletons Sales and Revenue by Type (2020-2031)
8.4 Europe Bionic Prosthetics and Exoskeletons Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Bionic Prosthetics and Exoskeletons Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia

9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Bionic Prosthetics and Exoskeletons Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Bionic Prosthetics and Exoskeletons Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Bionic Prosthetics and Exoskeletons Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India

10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Bionic Prosthetics and Exoskeletons Sales and Revenue by Type (2020-2031)
10.4 Central and South America Bionic Prosthetics and Exoskeletons Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Bionic Prosthetics and Exoskeletons Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Bionic Prosthetics and Exoskeletons Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Bionic Prosthetics and Exoskeletons Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Bionic Prosthetics and Exoskeletons Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa

12 Corporate Profile
12.1 Ekso Bionics
12.1.1 Ekso Bionics Corporation Information
12.1.2 Ekso Bionics Business Overview
12.1.3 Ekso Bionics Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.1.4 Ekso Bionics Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ekso Bionics Bionic Prosthetics and Exoskeletons Sales by Product in 2024
12.1.6 Ekso Bionics Bionic Prosthetics and Exoskeletons Sales by Application in 2024
12.1.7 Ekso Bionics Bionic Prosthetics and Exoskeletons Sales by Geographic Area in 2024
12.1.8 Ekso Bionics Bionic Prosthetics and Exoskeletons SWOT Analysis
12.1.9 Ekso Bionics Recent Developments
12.2 Lifeward
12.2.1 Lifeward Corporation Information
12.2.2 Lifeward Business Overview
12.2.3 Lifeward Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.2.4 Lifeward Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Lifeward Bionic Prosthetics and Exoskeletons Sales by Product in 2024
12.2.6 Lifeward Bionic Prosthetics and Exoskeletons Sales by Application in 2024
12.2.7 Lifeward Bionic Prosthetics and Exoskeletons Sales by Geographic Area in 2024
12.2.8 Lifeward Bionic Prosthetics and Exoskeletons SWOT Analysis
12.2.9 Lifeward Recent Developments
12.3 Cyberdyne
12.3.1 Cyberdyne Corporation Information
12.3.2 Cyberdyne Business Overview
12.3.3 Cyberdyne Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.3.4 Cyberdyne Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Cyberdyne Bionic Prosthetics and Exoskeletons Sales by Product in 2024
12.3.6 Cyberdyne Bionic Prosthetics and Exoskeletons Sales by Application in 2024
12.3.7 Cyberdyne Bionic Prosthetics and Exoskeletons Sales by Geographic Area in 2024
12.3.8 Cyberdyne Bionic Prosthetics and Exoskeletons SWOT Analysis
12.3.9 Cyberdyne Recent Developments
12.4 Open Bionics
12.4.1 Open Bionics Corporation Information
12.4.2 Open Bionics Business Overview
12.4.3 Open Bionics Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.4.4 Open Bionics Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Open Bionics Bionic Prosthetics and Exoskeletons Sales by Product in 2024
12.4.6 Open Bionics Bionic Prosthetics and Exoskeletons Sales by Application in 2024
12.4.7 Open Bionics Bionic Prosthetics and Exoskeletons Sales by Geographic Area in 2024
12.4.8 Open Bionics Bionic Prosthetics and Exoskeletons SWOT Analysis
12.4.9 Open Bionics Recent Developments
12.5 SUITX Exoskeletons
12.5.1 SUITX Exoskeletons Corporation Information
12.5.2 SUITX Exoskeletons Business Overview
12.5.3 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.5.4 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons Sales by Product in 2024
12.5.6 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons Sales by Application in 2024
12.5.7 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons Sales by Geographic Area in 2024
12.5.8 SUITX Exoskeletons Bionic Prosthetics and Exoskeletons SWOT Analysis
12.5.9 SUITX Exoskeletons Recent Developments
12.6 Marsi Bionics
12.6.1 Marsi Bionics Corporation Information
12.6.2 Marsi Bionics Business Overview
12.6.3 Marsi Bionics Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.6.4 Marsi Bionics Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Marsi Bionics Recent Developments
12.7 Ottobock
12.7.1 Ottobock Corporation Information
12.7.2 Ottobock Business Overview
12.7.3 Ottobock Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.7.4 Ottobock Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Ottobock Recent Developments
12.8 Esper Bionics
12.8.1 Esper Bionics Corporation Information
12.8.2 Esper Bionics Business Overview
12.8.3 Esper Bionics Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.8.4 Esper Bionics Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Esper Bionics Recent Developments
12.9 Bionic
12.9.1 Bionic Corporation Information
12.9.2 Bionic Business Overview
12.9.3 Bionic Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.9.4 Bionic Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Bionic Recent Developments
12.10 Coapt
12.10.1 Coapt Corporation Information
12.10.2 Coapt Business Overview
12.10.3 Coapt Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.10.4 Coapt Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Coapt Recent Developments
12.11 Blatchford
12.11.1 Blatchford Corporation Information
12.11.2 Blatchford Business Overview
12.11.3 Blatchford Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.11.4 Blatchford Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Blatchford Recent Developments
12.12 FAULHABER GROUP
12.12.1 FAULHABER GROUP Corporation Information
12.12.2 FAULHABER GROUP Business Overview
12.12.3 FAULHABER GROUP Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.12.4 FAULHABER GROUP Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 FAULHABER GROUP Recent Developments
12.13 Parker Hannifin
12.13.1 Parker Hannifin Corporation Information
12.13.2 Parker Hannifin Business Overview
12.13.3 Parker Hannifin Bionic Prosthetics and Exoskeletons Product Models, Descriptions and Specifications
12.13.4 Parker Hannifin Bionic Prosthetics and Exoskeletons Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Parker Hannifin Recent Developments

13 Value Chain and Supply-Chain Analysis
13.1 Bionic Prosthetics and Exoskeletons Industry Chain
13.2 Bionic Prosthetics and Exoskeletons Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Bionic Prosthetics and Exoskeletons Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Bionic Prosthetics and Exoskeletons Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors

14 Bionic Prosthetics and Exoskeletons Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Bionic Prosthetics and Exoskeletons Study

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Bionic Prosthetics and Exoskeletons Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bionic Prosthetics and Exoskeletons Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bionic Prosthetics and Exoskeletons Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bionic Prosthetics and Exoskeletons Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Bionic Prosthetics and Exoskeletons Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Bionic Prosthetics and Exoskeletons Sales by Region (2020-2025) & (K Units)
 Table 8. Global Bionic Prosthetics and Exoskeletons Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Bionic Prosthetics and Exoskeletons Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 11. Global Bionic Prosthetics and Exoskeletons Production by Region (2020-2025) & (K Units)
 Table 12. Global Bionic Prosthetics and Exoskeletons Production by Region (2026-2031) & (K Units)
 Table 13. Global Bionic Prosthetics and Exoskeletons Sales by Manufacturers (2020-2025) & (K Units)
 Table 14. Global Bionic Prosthetics and Exoskeletons Sales Share by Manufacturers (2020-2025)
 Table 15. Global Bionic Prosthetics and Exoskeletons Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Bionic Prosthetics and Exoskeletons Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Bionic Prosthetics and Exoskeletons by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bionic Prosthetics and Exoskeletons as of 2024)
 Table 19. Global Bionic Prosthetics and Exoskeletons Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Bionic Prosthetics and Exoskeletons Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 21. Key Manufacturers Bionic Prosthetics and Exoskeletons Manufacturing Base and Headquarters
 Table 22. Global Bionic Prosthetics and Exoskeletons Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Bionic Prosthetics and Exoskeletons Sales by Type (2020-2025) & (K Units)
 Table 26. Global Bionic Prosthetics and Exoskeletons Sales by Type (2026-2031) & (K Units)
 Table 27. Global Bionic Prosthetics and Exoskeletons Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Bionic Prosthetics and Exoskeletons Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Bionic Prosthetics and Exoskeletons ASP by Type (2020-2031) & (US$/Unit)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Bionic Prosthetics and Exoskeletons Sales by Application (2020-2025) & (K Units)
 Table 32. Global Bionic Prosthetics and Exoskeletons Sales by Application (2026-2031) & (K Units)
 Table 33. Bionic Prosthetics and Exoskeletons High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Bionic Prosthetics and Exoskeletons Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Bionic Prosthetics and Exoskeletons Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Bionic Prosthetics and Exoskeletons ASP by Application (2020-2031) & (US$/Unit)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Bionic Prosthetics and Exoskeletons Growth Accelerators and Market Barriers
 Table 40. North America Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Bionic Prosthetics and Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Bionic Prosthetics and Exoskeletons Growth Accelerators and Market Barriers
 Table 43. Europe Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Bionic Prosthetics and Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Bionic Prosthetics and Exoskeletons Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Bionic Prosthetics and Exoskeletons Investment Opportunities and Key Challenges
 Table 50. Central and South America Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Bionic Prosthetics and Exoskeletons Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Bionic Prosthetics and Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Ekso Bionics Corporation Information
 Table 54. Ekso Bionics Description and Major Businesses
 Table 55. Ekso Bionics Product Models, Descriptions and Specifications
 Table 56. Ekso Bionics Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 57. Ekso Bionics Sales Value Proportion by Product in 2024
 Table 58. Ekso Bionics Sales Value Proportion by Application in 2024
 Table 59. Ekso Bionics Sales Value Proportion by Geographic Area in 2024
 Table 60. Ekso Bionics Bionic Prosthetics and Exoskeletons SWOT Analysis
 Table 61. Ekso Bionics Recent Developments
 Table 62. Lifeward Corporation Information
 Table 63. Lifeward Description and Major Businesses
 Table 64. Lifeward Product Models, Descriptions and Specifications
 Table 65. Lifeward Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 66. Lifeward Sales Value Proportion by Product in 2024
 Table 67. Lifeward Sales Value Proportion by Application in 2024
 Table 68. Lifeward Sales Value Proportion by Geographic Area in 2024
 Table 69. Lifeward Bionic Prosthetics and Exoskeletons SWOT Analysis
 Table 70. Lifeward Recent Developments
 Table 71. Cyberdyne Corporation Information
 Table 72. Cyberdyne Description and Major Businesses
 Table 73. Cyberdyne Product Models, Descriptions and Specifications
 Table 74. Cyberdyne Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Cyberdyne Sales Value Proportion by Product in 2024
 Table 76. Cyberdyne Sales Value Proportion by Application in 2024
 Table 77. Cyberdyne Sales Value Proportion by Geographic Area in 2024
 Table 78. Cyberdyne Bionic Prosthetics and Exoskeletons SWOT Analysis
 Table 79. Cyberdyne Recent Developments
 Table 80. Open Bionics Corporation Information
 Table 81. Open Bionics Description and Major Businesses
 Table 82. Open Bionics Product Models, Descriptions and Specifications
 Table 83. Open Bionics Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 84. Open Bionics Sales Value Proportion by Product in 2024
 Table 85. Open Bionics Sales Value Proportion by Application in 2024
 Table 86. Open Bionics Sales Value Proportion by Geographic Area in 2024
 Table 87. Open Bionics Bionic Prosthetics and Exoskeletons SWOT Analysis
 Table 88. Open Bionics Recent Developments
 Table 89. SUITX Exoskeletons Corporation Information
 Table 90. SUITX Exoskeletons Description and Major Businesses
 Table 91. SUITX Exoskeletons Product Models, Descriptions and Specifications
 Table 92. SUITX Exoskeletons Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. SUITX Exoskeletons Sales Value Proportion by Product in 2024
 Table 94. SUITX Exoskeletons Sales Value Proportion by Application in 2024
 Table 95. SUITX Exoskeletons Sales Value Proportion by Geographic Area in 2024
 Table 96. SUITX Exoskeletons Bionic Prosthetics and Exoskeletons SWOT Analysis
 Table 97. SUITX Exoskeletons Recent Developments
 Table 98. Marsi Bionics Corporation Information
 Table 99. Marsi Bionics Description and Major Businesses
 Table 100. Marsi Bionics Product Models, Descriptions and Specifications
 Table 101. Marsi Bionics Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 102. Marsi Bionics Recent Developments
 Table 103. Ottobock Corporation Information
 Table 104. Ottobock Description and Major Businesses
 Table 105. Ottobock Product Models, Descriptions and Specifications
 Table 106. Ottobock Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 107. Ottobock Recent Developments
 Table 108. Esper Bionics Corporation Information
 Table 109. Esper Bionics Description and Major Businesses
 Table 110. Esper Bionics Product Models, Descriptions and Specifications
 Table 111. Esper Bionics Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 112. Esper Bionics Recent Developments
 Table 113. Bionic Corporation Information
 Table 114. Bionic Description and Major Businesses
 Table 115. Bionic Product Models, Descriptions and Specifications
 Table 116. Bionic Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 117. Bionic Recent Developments
 Table 118. Coapt Corporation Information
 Table 119. Coapt Description and Major Businesses
 Table 120. Coapt Product Models, Descriptions and Specifications
 Table 121. Coapt Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 122. Coapt Recent Developments
 Table 123. Blatchford Corporation Information
 Table 124. Blatchford Description and Major Businesses
 Table 125. Blatchford Product Models, Descriptions and Specifications
 Table 126. Blatchford Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 127. Blatchford Recent Developments
 Table 128. FAULHABER GROUP Corporation Information
 Table 129. FAULHABER GROUP Description and Major Businesses
 Table 130. FAULHABER GROUP Product Models, Descriptions and Specifications
 Table 131. FAULHABER GROUP Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 132. FAULHABER GROUP Recent Developments
 Table 133. Parker Hannifin Corporation Information
 Table 134. Parker Hannifin Description and Major Businesses
 Table 135. Parker Hannifin Product Models, Descriptions and Specifications
 Table 136. Parker Hannifin Capacity, Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 137. Parker Hannifin Recent Developments
 Table 138. Key Raw Materials Distribution
 Table 139. Raw Materials Key Suppliers
 Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 141. Milestones in Production Technology Evolution
 Table 142. Distributors List
 Table 143. Market Trends and Market Evolution
 Table 144. Market Drivers and Opportunities
 Table 145. Market Challenges, Risks, and Restraints
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bionic Prosthetics and Exoskeletons Product Picture
 Figure 2. Global Bionic Prosthetics and Exoskeletons Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Upper Limbs Product Picture
 Figure 4. Lower Limbs Product Picture
 Figure 5. Whole Body Product Picture
 Figure 6. Global Bionic Prosthetics and Exoskeletons Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Military
 Figure 8. Civilian
 Figure 9. Medical
 Figure 10. Others
 Figure 11. Bionic Prosthetics and Exoskeletons Report Years Considered
 Figure 12. Global Bionic Prosthetics and Exoskeletons Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Bionic Prosthetics and Exoskeletons Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Bionic Prosthetics and Exoskeletons Revenue Market Share by Region (2020-2031)
 Figure 16. Global Bionic Prosthetics and Exoskeletons Sales (2020-2031) & (K Units)
 Figure 17. Global Bionic Prosthetics and Exoskeletons Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Bionic Prosthetics and Exoskeletons Sales Market Share by Region (2020-2031)
 Figure 19. Global Bionic Prosthetics and Exoskeletons Capacity, Production and Utilization (2020-2031) & (K Units)
 Figure 20. Global Bionic Prosthetics and Exoskeletons Production Trend by Region (2020-2031) (K Units)
 Figure 21. Global Bionic Prosthetics and Exoskeletons Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. Bionic Prosthetics and Exoskeletons Production Growth Rate in North America (2020-2031) & (K Units)
 Figure 24. Bionic Prosthetics and Exoskeletons Production Growth Rate in Europe (2020-2031) & (K Units)
 Figure 25. Bionic Prosthetics and Exoskeletons Production Growth Rate in China (2020-2031) & (K Units)
 Figure 26. Bionic Prosthetics and Exoskeletons Production Growth Rate in Japan (2020-2031) & (K Units)
 Figure 27. Top 5 and Top 10 Manufacturers Bionic Prosthetics and Exoskeletons Sales Volume Market Share in 2024
 Figure 28. Global Bionic Prosthetics and Exoskeletons Revenue Market Share Ranking (2024)
 Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 30. Upper Limbs Revenue Market Share by Manufacturer in 2024
 Figure 31. Lower Limbs Revenue Market Share by Manufacturer in 2024
 Figure 32. Whole Body Revenue Market Share by Manufacturer in 2024
 Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 35. Global Bionic Prosthetics and Exoskeletons Sales Market Share by Type (2020-2031)
 Figure 36. Global Bionic Prosthetics and Exoskeletons Revenue Market Share by Type (2020-2031)
 Figure 37. Global Bionic Prosthetics and Exoskeletons Sales Market Share by Application (2020-2031)
 Figure 38. Global Bionic Prosthetics and Exoskeletons Revenue Market Share by Application (2020-2031)
 Figure 39. North America Bionic Prosthetics and Exoskeletons Sales YoY (2020-2031) & (K Units)
 Figure 40. North America Bionic Prosthetics and Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. North America Top 5 Manufacturers Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) in 2024
 Figure 42. North America Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Type (2020- 2031)
 Figure 43. North America Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 44. North America Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Application (2020-2031)
 Figure 45. North America Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. US Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 47. Canada Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 48. Mexico Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 49. Europe Bionic Prosthetics and Exoskeletons Sales YoY (2020-2031) & (K Units)
 Figure 50. Europe Bionic Prosthetics and Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Europe Top 5 Manufacturers Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) in 2024
 Figure 52. Europe Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Type (2020-2031)
 Figure 53. Europe Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Europe Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Europe Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Germany Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 57. France Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 58. U.K. Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 59. Italy Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 60. Russia Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales YoY (2020-2031) & (K Units)
 Figure 62. Asia-Pacific Bionic Prosthetics and Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Asia-Pacific Top 8 Manufacturers Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) in 2024
 Figure 64. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Type (2020- 2031)
 Figure 65. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 66. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Asia-Pacific Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Indonesia Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 69. Japan Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 70. South Korea Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 71. China Taiwan Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 72. India Bionic Prosthetics and Exoskeletons Revenue (2020-2031) & (US$ Million)
 Figure 73. Central and South America Bionic Prosthetics and Exoskeletons Sales YoY (2020-2031) & (K Units)
 Figure 74. Central and South America Bionic Prosthetics and Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Central and South America Top 5 Manufacturers Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) in 2024
 Figure 76. Central and South America Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Type (2021-2031)
 Figure 77. Central and South America Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Central and South America Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Application (2020-2031)
 Figure 79. Central and South America Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. Brazil Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 81. Argentina Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 82. Middle East, and Africa Bionic Prosthetics and Exoskeletons Sales YoY (2020-2031) & (K Units)
 Figure 83. Middle East and Africa Bionic Prosthetics and Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
 Figure 84. Middle East and Africa Top 5 Manufacturers Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) in 2024
 Figure 85. Middle East and Africa Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Type (2021-2031)
 Figure 86. South America Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 87. Middle East and Africa Bionic Prosthetics and Exoskeletons Sales Volume (K Units) by Application (2020-2031)
 Figure 88. Middle East and Africa Bionic Prosthetics and Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 89. GCC Countries Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 90. Turkey Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 91. Egypt Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 92. South Africa Bionic Prosthetics and Exoskeletons Revenue (2020-2025) & (US$ Million)
 Figure 93. Bionic Prosthetics and Exoskeletons Industry Chain Mapping
 Figure 94. Regional Bionic Prosthetics and Exoskeletons Manufacturing Base Distribution (%)
 Figure 95. Bionic Prosthetics and Exoskeletons Production Process
 Figure 96. Regional Bionic Prosthetics and Exoskeletons Production Cost Structure
 Figure 97. Channels of Distribution (Direct Vs Distribution)
 Figure 98. Bottom-up and Top-down Approaches for This Report
 Figure 99. Data Triangulation
 Figure 100. Key Executives Interviewed

以下、関連資料のご紹介